Trade INC Research - SYNH CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.09 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.023346% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.001124% | ||||||||
| Overnight fee time | 21:00 (UTC) | ||||||||
| Min traded quantity | 1 | ||||||||
| Currency | USD | ||||||||
| Margin | 5.00% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
| Prev. Close | 42.93 |
| Open | 42.93 |
| 1-Year Change | -9.92% |
| Day's Range | 42.93 - 42.94 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Sep 27, 2023 | 42.93 | 0.00 | 0.00% | 42.93 | 42.94 | 42.93 |
| Sep 26, 2023 | 42.93 | 0.22 | 0.52% | 42.71 | 42.94 | 42.70 |
| Sep 25, 2023 | 42.73 | 0.04 | 0.09% | 42.69 | 42.75 | 42.69 |
| Sep 22, 2023 | 42.68 | -0.08 | -0.19% | 42.76 | 42.77 | 42.68 |
| Sep 21, 2023 | 42.73 | -0.01 | -0.02% | 42.74 | 42.74 | 42.71 |
| Sep 20, 2023 | 42.75 | -0.04 | -0.09% | 42.79 | 42.80 | 42.74 |
| Sep 19, 2023 | 42.78 | 0.05 | 0.12% | 42.73 | 42.78 | 42.73 |
| Sep 18, 2023 | 42.74 | 0.03 | 0.07% | 42.71 | 42.74 | 42.71 |
| Sep 15, 2023 | 42.70 | -0.03 | -0.07% | 42.73 | 42.78 | 42.70 |
| Sep 14, 2023 | 42.73 | 0.01 | 0.02% | 42.72 | 42.78 | 42.71 |
| Sep 13, 2023 | 42.73 | 0.03 | 0.07% | 42.70 | 42.76 | 42.70 |
| Sep 12, 2023 | 42.70 | -0.02 | -0.05% | 42.72 | 42.74 | 42.70 |
| Sep 11, 2023 | 42.72 | 0.07 | 0.16% | 42.65 | 42.72 | 42.65 |
| Sep 8, 2023 | 42.66 | -0.02 | -0.05% | 42.68 | 42.71 | 42.66 |
| Sep 7, 2023 | 42.69 | -0.02 | -0.05% | 42.71 | 42.73 | 42.69 |
| Sep 6, 2023 | 42.72 | 0.02 | 0.05% | 42.70 | 42.80 | 42.69 |
| Sep 5, 2023 | 42.68 | -0.01 | -0.02% | 42.69 | 42.70 | 42.56 |
| Sep 1, 2023 | 42.66 | 0.08 | 0.19% | 42.58 | 42.69 | 42.58 |
| Aug 31, 2023 | 42.68 | 0.04 | 0.09% | 42.64 | 42.68 | 42.61 |
| Aug 30, 2023 | 42.64 | 0.08 | 0.19% | 42.56 | 42.65 | 42.55 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 3:1
- 5:1
- 10:1
- 20:1
- 20
- 100
- 500
- 1000
- 10000
INC Research Company profile
About Syneos Health Inc
Syneos Health, Inc. is a biopharmaceutical solutions company. It provides a range of clinical and commercial services to customers in the pharmaceutical, biotechnology, and healthcare industries. It offers both stand-alone and integrated biopharmaceutical product development solutions ranging from Early Phase (Phase I) clinical trials to the full commercialization of biopharmaceutical products. It operates through two business segments: Clinical Solutions and Commercial Solutions. Clinical Solutions segment offers global services for the development of diagnostics, drugs, biologics, devices, and digital therapeutics that span Phase I to IV of clinical development. The segment offers individual services including product development, project management, protocol development, investigational site recruitment, and clinical monitoring. The Commercial Solutions segment provides commercialization services, including deployment solutions, communication solutions, and consulting services.
Financial summary
BRIEF: For the fiscal year ended 31 December 2021, Syneos Health Inc revenues increased 18% to $5.21B. Net income increased 22% to $234.8M. Revenues reflect Clinical Solutions segment increase of 21% to $4.01B, Commercial Solutions segment increase of 9% to $1.2B, North America segment increase of 13% to $3.14B, Europe, Middle East and Africa segment increase of 26% to $1.33B, Asia-Pacific segment increase of 28% to $594.2M.
| Industry: | Biotechnology & Medical Research (NEC) |
1030 Sync Street
MORRISVILLE
NORTH CAROLINA 27560
US
News
ECB interest-rate forecasts – Projections for the next five years
The European Central Bank (ECB) plays a pivotal role in the economic stability of the eurozone, meaning ECB interest-rate forecasts are key to understanding how financial and economic scenarios might evolve.
14:37, 10 April 2025
BlackRock shareholders: Who owns the most BLK stock?
BlackRock is the leading asset manager in the world – but who are its biggest shareholders? Read on to find out.
13:46, 9 April 2025
Bitcoin price predictions 2025–2050: third-party price target
We examine bitcoin price predictions for 2025 and beyond, with insights from third-party analysts and market experts.
10:28, 9 April 2025
Tesla (TSLA) stock forecast 2025 and beyond: third-party Tesla price target
Where will Tesla’s stock be in five years? Can the EV company keep its crown?
08:19, 9 April 2025
JasmyCoin price predictions 2025-2030: Third-party price target
How might JASMY behave in the future?
16:13, 8 April 2025
Australian interest-rate projections: where will rates be in 5 years?
As one of the most closely watched economic indicators, Australian interest-rate projections offer valuable insight into the future of the country’s economy.
21:37, 7 April 2025
Copper price forecast: third-party price target
What’s next for the copper market? Read on for the latest analysis of the commodity's price and potential outlook.
17:31, 14 March 2025People also watch
Still looking for a broker you can trust?
Join the 720,000+ traders worldwide that chose to trade with Capital.com